ASTRAZENECA AB vs Philips North America: FDA Enforcement Comparison

Philips North America has been the subject of 369 FDA enforcement/approval records tracked by Argus HQ, compared to 1 for ASTRAZENECA AB.

ASTRAZENECA AB: 0 warning letters, 0 recalls, 1 approval record, 0 Form 483s.

Philips North America: 0 warning letters, 369 recalls, 0 approval records, 0 Form 483s.

Side by side

ASTRAZENECA AB — Warning letters0

Philips North America — Warning letters0

ASTRAZENECA AB — Recalls0

Philips North America — Recalls369

ASTRAZENECA AB — Approval records1

Philips North America — Approval records0

ASTRAZENECA AB — Form 483s0

Philips North America — Form 483s0

Timeline

ASTRAZENECA AB

Most recent FDA action: October 8, 2026

Full history →

Philips North America

Most recent FDA action: October 7, 2026

Full history →

Cite this comparison

Pre-formatted for a story, footnote, or reference list:

"ASTRAZENECA AB vs Philips North America: FDA Enforcement Comparison." Argus HQ, accessed October 14, 2026. https://argushq.ai/compare/astrazeneca-ab-vs-philips-north-america

Source: FDA.gov (aggregated across Warning Letters, Recalls, Approvals, Form 483s) ↗